Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker DYNC
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 29, 2026 | Dynamix Corp | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 30, 2026 | Dynamix Corp | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 10, 2026 | Dynamix Corp | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 10, 2026 | Dynamix Corp | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Sep 16, 2025 | Dynamix Corp | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 9, 2025 | Dynamix Corp | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 2, 2025 | Dynamix Corp | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 2, 2025 | Dynamix Corp | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 2, 2025 | Dynamix Corp | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Sep 2, 2025 | Dynamix Corp | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 26, 2025 | Dynamix Corp | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 6, 2025 | Dynamix Corp | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 4, 2025 | Dynamix Corp | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 25, 2025 | Dynamix Corp | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 25, 2025 | Dynamix Corp | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jul 25, 2025 | Dynamix Corp | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 21, 2025 | Dynamix Corp | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 7, 2025 | Dynamix Corp | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 6, 2024 | Dynamix Corp | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 3, 2024 | Dynamix Corp | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 22, 2024 | Dynamix Corp | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 22, 2024 | Dynamix Corp | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 22, 2024 | Dynamix Corp | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 22, 2024 | Dynamix Corp | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 22, 2024 | Dynamix Corp | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Nov 22, 2024 | Dynamix Corp | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
26 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:55 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances